|Beitragstitel||Using survival rate benchmarks as opportunity to improve decision-making of orthopaedic medical devices in Mexico.|
To control the financial impact of joint replacement it is important to achieve good survival rates of the used implants. Arthroplasty register data shows that the clinical performance of hip and knee implants in the long-term demonstrate a strong variation. Using poorly performing implants increases the revision risk. Yet, little is known about health policies encompassing strategies to decrease the use of poorly performing hip and knee implants. This paper aims to analyse the contribution of survival rate benchmarks as decision-making rule and presents first a brief discussion of issues concerning medical devices and second, it reviews the use of survival rate benchmarks of orthopaedic implants as „do not do recommendations“-rule for decision-making in Mexico. Finally, it discusses the health economic contribution of introducing survival rate benchmarks.
The content of this manuscript is novel as it establishes a critical policy perspective on how survival rate benchmarks (as they are established in the United Kingdom) may contribute as “do-not-do recommendation” to decision makers in health systems that lack high-quality data for orthopaedic procedures such as in Mexico. To date, little has been published on technology policies in Mexico for orthopaedic high-risk medical devices. However, few studies suggest that improvements are needed to prevent economic and health burden due to purchasing decision-making that lack to adequately consider survival rate data and thus purchasing sub-standard implants that may increase the revision risk.
The findings of this article are primarily relevant for medical devices in Mexico, but may also encourage policy discussion in other health system that lack high-quality data for orthopaedic procedures. Using survival rate benchmarks may positively impact on revision rates and financial burden. Introducing these survival rate benchmarks may improve the eligibility of medical devices, strengthen quality assurance, and enhance organisational governance. The Mexican health system lacks high-quality data for orthopaedic surgeries. However, average survival rates from different arthroplasty registries could be used as reference. Economic analysis in orthopaedic provides a powerful tool for evaluation of health-care technologies and treatment strategies.